{
    "company_name": "EMYRIA LIMITED",
    "address": "D2, 661 Newcastle Street, LEEDERVILLE, WA, AUSTRALIA, 6007",
    "summary": "Operates a network of specialist medical clinics and uses purpose built software and technology to gather clinical data from consenting patients. The anonymised data is commercialised as clinical evidence.",
    "details": "Operates a network of specialist medical clinics and uses purpose built software and technology to gather clinical data from consenting patients. The anonymised data is commercialised as clinical evidence.",
    "website": "https://emyria.com/",
    "stock_code": "EMD",
    "links": "['#content', 'https://emyria.com', 'https://emyria.com/', 'https://emyria.com/team', '/healthcare', 'https://emyria.com/patient-first-statement/', '/pipeline', '#', 'https://investorhub.emyria.com/', 'https://emyria.com/about/corporate-governance/', 'https://emyria.com/investor-hub/shareholder-communications/', 'https://emyria.com/news/', 'https://emyria.com/contact/', 'https://emyria.com/', 'https://emyria.com/team', '/healthcare', 'https://emyria.com/patient-first-statement/', '/pipeline', '#', 'https://investorhub.emyria.com/', 'https://emyria.com/about/corporate-governance/', 'https://emyria.com/investor-hub/shareholder-communications/', 'https://emyria.com/news/', 'https://emyria.com/contact/', '#research-and-development', '/pipeline', '/team', 'https://investorhub.emyria.com/', 'https://emyria.com/news/equity-mates-podcast-uncovered-emyria/', 'https://emyria.com/news/2024/03/01/', 'https://emyria.com/news/equity-mates-podcast-uncovered-emyria/', 'https://emyria.com/news/half-year-financial-report-period-ending-31-december-2023/', 'https://emyria.com/news/2024/02/28/', 'https://emyria.com/news/half-year-financial-report-period-ending-31-december-2023/', 'https://emyria.com/news/quarterly-report-period-ending-31-december-2023/', 'https://emyria.com/news/2024/01/31/', 'https://emyria.com/news/quarterly-report-period-ending-31-december-2023/', 'https://emyria.com/news/australian-financial-review-january-2024/', 'https://emyria.com/news/2024/01/22/', 'https://emyria.com/news/australian-financial-review-january-2024/', 'https://emyria.com/news/emyria-specialist-granted-authorised-prescriber-status/', 'https://emyria.com/news/2024/01/10/', 'https://emyria.com/news/emyria-specialist-granted-authorised-prescriber-status/', 'https://emyria.com/news/proactive-interview/', 'https://emyria.com/news/2023/11/23/', 'https://emyria.com/news/proactive-interview/', 'https://emyria.com/news/new-independent-non-executive-chairman/', 'https://emyria.com/news/2023/11/21/', 'https://emyria.com/news/new-independent-non-executive-chairman/', 'https://emyria.com/news/large-australian-study-finds-medicinal-cannabis-may-have-significant-impact-on-quality-of-life/', 'https://emyria.com/news/2023/05/10/', 'https://emyria.com/news/large-australian-study-finds-medicinal-cannabis-may-have-significant-impact-on-quality-of-life/', 'https://emyria.com/news/emyria-unveils-highest-potency-cbd-capsule-for-fda-pathway/', 'https://emyria.com/news/2023/04/24/', 'https://emyria.com/news/emyria-unveils-highest-potency-cbd-capsule-for-fda-pathway/', 'https://emyria.com/news/emyria-to-develop-psilocybin-therapy-care-model/', 'https://emyria.com/news/2023/04/17/', 'https://emyria.com/news/emyria-to-develop-psilocybin-therapy-care-model/', '/healthcare', '/pipeline', 'https://investorhub.emyria.com/', '/healthcare', '/pipeline', 'https://investorhub.emyria.com/', 'https://investorhub.emyria.com/auth/signup', 'https://www.glideagency.com/', 'https://emyria.com/terms/', 'https://emyria.com/privacy-policy/', 'https://emyria.com/terms/', 'https://emyria.com/privacy-policy/', 'tel:0865592800', 'mailto:info@emyria.com', 'https://www.linkedin.com/company/emyria', 'https://twitter.com/EmyriaGlobal', 'https://www.youtube.com/channel/UCgVOJIxzgSzX_Yc4n5ciyQw']",
    "images": "data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/emyria-logo.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/01/ONE_1400x1400.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/01/TWO_1400x1400.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-1.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-5.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-3.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-2.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-4.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/Partner-Logos-for-Website-6.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/03/EMD-Equity-Mates-350-x-220-px.gif, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/02/240228_EMD-Half-Yearly-Report-350-x-220-px.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/01/310124-EMD-Quarterly-Report-350-x-220-px.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/01/EMD-AUSTRALIAN-FINANCIAL-REVIEW-350-x-220-px-1.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2024/01/Authorised-Prescriber-Status-Granted-350-x-220-px.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/11/Blog_Proactive_EMD-News-Tile_350-X-220.jpg, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/11/2311-Emyria-News_Greg-Hutchinson_350x220.jpg, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/05/Post_Study-finds-Medicinal-Cannabis-May-Have-Impact-on-Quality-of-Life.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/04/Post_Emyria-Unveils-Highest-Potency-CBD-Capsule-for-FDA-Pathway.png, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/04/Post_Emyria-to-Develop-Psilocybin-Therapy-Care-Model.jpeg, data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==, https://emyria.com/wp-content/uploads/2023/08/emyria-logo-carol-1.png",
    "company_logo_link": "https://emyria.com/wp-content/uploads/2023/08/emyria-logo.png"
}